Poster # 25: PRECLINICAL EVALUATION OF A MODIFIED MRNA FOR THE TREATMENT OF OTC DEFICIENCYSeptember 9, 2020September 9, 2020 Leave your questions or comments for the authors in the comment section, below. Click on the image to view the PDF. previousPoster # 24: Rethinking the Pertussis vaccine: Formulation of lipid nanoparticles with vaccine adjuvants to achieve enhanced immunitynextPoster # 27: A subunit vaccine for bovine viral diarrhea: lipid-based formulation containing bovine viral diarrheas virus E2 protein in combination with adjuvants to improve immunogenicity